Overuse of short-acting β<sub>2</sub>-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programmeBright I. Nwaru, Christer Janson, Gunilla Telg et al.|European Respiratory Journal|2020Cited by 447
Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in SwedenMagnus Ekström, Christer Janson, Bright I. Nwaru et al.|Allergy|2019Cited by 93